Does the revised International Federation of Gynecology and Obstetrics staging system for endometrial cancer lead to increased discrimination in patient outcomes?

Cancer

Volumn 117, Issue 18, 2011, Pages 4231-4237

  Cooke, Ellen W ^a   Pappas, Lisa ^b   Gaffney, David K ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF UTAH   (United States)

Author keywords

endometrial cancer; International Federation of Gynecology and Obstetrics staging; lymph node; pelvic washings; peritoneal washings

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CANCER GRADING; CANCER STAGING; CAUSE SPECIFIC SURVIVAL; CONTROLLED STUDY; ENDOMETRIUM CARCINOMA; FEMALE; FOLLOW UP; HUMAN; INTERNATIONAL FEDERATION OF GYNECOLOGY AND OBSTETRICS STAGING SYSTEM; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RACE; UNIVARIATE ANALYSIS;

ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; SEER PROGRAM; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 80052511021     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.26030     Document Type: Article

References (25)

1. Pecorelli S,. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet. 2009; 105: 103-104.
2. Creasman W,. Revised FIGO staging for carcinoma of the endometrium. Int J Gynaecol Obstet. 2009; 105: 109.
3. Creutzberg CL, van Putten WL, Warlam-Rodenhuis CC, et al. Outcome of high-risk stage IC, grade 3, compared with stage I endometrial carcinoma patients: the Postoperative Radiation Therapy in Endometrial Carcinoma Trial. J Clin Oncol. 2004; 22: 1234-1241. (Pubitemid 41079837)
4. Denschlag D, Tan L, Patel S, Kerim-Dikeni A, Souhami L, Gilbert L,. Stage III endometrial cancer: preoperative predictability, prognostic factors, and treatment outcome [serial online]. Am J Obstet Gynecol. 2007; 196: 546, e1-e7.
5. Wong FC, Pang CP, Tang SK, et al. Treatment results of endometrial carcinoma with positive peritoneal washing, adnexal involvement and serosal involvement. Clin Oncol (R Coll Radiol). 2004; 16: 350-355. (Pubitemid 38967256)
6. Slomovitz BM, Ramondetta LM, Lee CM, et al. Heterogeneity of stage IIIA endometrial carcinomas: implications for adjuvant therapy. Int J Gynecol Cancer. 2005; 15: 510-516. (Pubitemid 40705549)
7. Fadare O, Mariappan MR, Hileeto D, Wang S, McAlpine JN, Rimm DL,. Upstaging based solely on positive peritoneal washing does not affect outcome in endometrial cancer. Mod Pathol. 2005; 18: 673-680. (Pubitemid 40676379)
8. Tebeu PM, Popowski Y, Verkooijen HM, et al. Positive peritoneal cytology in early stage endometrial cancer does not influence prognosis. Br J Cancer. 2004; 91: 720-724. (Pubitemid 39141631)
9. Mariani A, Webb MJ, Keeney GL, Aletti G, Podratz KC,. Assessment of prognostic factors in stage IIIA endometrial cancer. Gynecol Oncol. 2002; 86: 38-44. (Pubitemid 34757049)
10. Takeshima N, Nishida H, Tabata T, Hirai Y, Hasumi K,. Positive peritoneal cytology in endometrial cancer: enhancement of other prognostic indicators. Gynecol Oncol. 2001; 82: 470-473. (Pubitemid 32826446)
11. Mariani A, Dowdy SC, Podratz KC,. New surgical staging of endometrial cancer: 20 years later. Int J Gynaecol Obstet. 2009; 105: 110-111.
12. Hirai Y, Takeshima N, Kato T, Hasumi K,. Malignant potential of positive peritoneal cytology in endometrial cancer. Obstet Gynecol. 2001; 97 (5 pt 1): 725-728.
13. Obermair A, Geramou M, Gucer F, et al. Does hysteroscopy facilitate tumor cell dissemination? Incidence of peritoneal cytology from patients with early stage endometrial carcinoma following dilatation and curettage (D&C) versus hysteroscopy and D&C. Cancer. 2000; 88: 139-143. (Pubitemid 30027689)
14. Mariani A, Webb MJ, Keeney GL, Haddock MG, Aletti G, Podratz KC,. Stage IIIC endometrioid corpus cancer includes distinct subgroups. Gynecol Oncol. 2002; 87: 112-117. (Pubitemid 36027110)
15. Mariani A, Dowdy SC, Cliby WA, et al. Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging. Gynecol Oncol. 2008; 109: 11-18.
16. Creasman WT, Morrow CP, Bundy BN, Homesley HD, Graham JE, Heller PB,. Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group study. Cancer. 1987; 60 (8 suppl): 2035-2041. (Pubitemid 17145924)
17. Chan JK, Cheung MK, Huh WK, et al. Therapeutic role of lymph node resection in endometrioid corpus cancer: a study of 12,333 patients. Cancer. 2006; 107: 1823-1830. (Pubitemid 44582951)
18. Kilgore LC, Partridge EE, Alvarez RD, et al. Adenocarcinoma of the endometrium: survival comparisons of patients with and without pelvic node sampling. Gynecol Oncol. 1995; 56: 29-33.
19. Morrow CP, Bundy BN, Kurman RJ, et al. Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study. Gynecol Oncol. 1991; 40: 55-65.
20. Todo Y, Kato H, Kaneuchi M, Watari H, Takeda M, Sakuragi N,. Survival Effect of Para-Aortic Lymphadenectomy in Endometrial Cancer (SEPAL study): a retrospective cohort analysis. Lancet. 2010; 375: 1165-1172.
21. Kitchener H, Swart AM, Qian Q, Amos C, Parmar MK,. Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet. 2009; 373: 125-136.
22. Benedetti Panici P, Basile S, Maneschi F, et al. Systematic pelvic lymphadenectomy vs no lymphadenectomy in early stage endometrial carcinoma: randomized clinical trial. J Natl Cancer Inst. 2008; 100: 1707-1716.
23. Geisler JP, Linnemeier GC, Manahan KJ,. Pelvic and para-aortic lymphadenectomy in patients with endometrioid adenocarcinoma of the endometrium. Int J Gynaecol Obstet. 2007; 98: 39-43. (Pubitemid 46898393)
24. Creutzberg CL, van Putten WL, Koper PC, et al. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma. Lancet. 2000; 355: 1404-1411. (Pubitemid 30215963)
25. Mariani A, Webb MJ, Keeney GL, Haddock MG, Calori G, Podratz KC,. Low-risk corpus cancer: is lymphadenectomy or radiotherapy necessary? Am J Obstet Gynecol. 2000; 182: 1506-1519. (Pubitemid 30437424)